Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders
Authors
Keywords
-
Journal
Hematology
Volume 21, Issue 4, Pages 218-224
Publisher
Informa UK Limited
Online
2015-07-15
DOI
10.1179/1607845415y.0000000031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estrogen Signaling Selectively Induces Apoptosis of Hematopoietic Progenitors and Myeloid Neoplasms without Harming Steady-State Hematopoiesis
- (2014) Abel Sánchez-Aguilera et al. Cell Stem Cell
- Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis
- (2014) A Tabarroki et al. LEUKEMIA
- Therapy for myeloproliferative neoplasms: when, which agent, and how?
- (2014) H. L. Geyer et al. Hematology-American Society of Hematology Education Program
- Protein tyrosine kinase regulation by ubiquitination: Critical roles of Cbl-family ubiquitin ligases
- (2012) Bhopal Mohapatra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
- (2012) Melissa Bowerman et al. BMC Medicine
- Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL
- (2011) Raghuveer Singh Mali et al. CANCER CELL
- Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage
- (2011) Guang Jian Liu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and Safety of Fasudil in Patients With Subarachnoid Hemorrhage: Final Results of a Randomized Trial of Fasudil Versus Nimodipine
- (2011) Jizong ZHAO et al. NEUROLOGIA MEDICO-CHIRURGICA
- Fasudil Decreases Lesion Burden in a Murine Model of Cerebral Cavernous Malformation Disease
- (2011) David A. McDonald et al. STROKE
- Cbl and Human Myeloid Neoplasms: The Cbl Oncogene Comes of Age: Figure 1.
- (2010) Stephen C. Kales et al. CANCER RESEARCH
- Western Blotting
- (2010) W. N. Burnette CLINICAL CHEMISTRY
- Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells
- (2010) M. Naramura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
- (2009) F. H. Grand et al. BLOOD
- Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies
- (2009) Hideki Makishima et al. JOURNAL OF CLINICAL ONCOLOGY
- Busulfan Produces Efficient Human Cell Engraftment in NOD/LtSz-Scid IL2RγNullMice
- (2008) Jun Hayakawa et al. STEM CELLS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started